Cell culture has long been a valuable tool for studying cell behaviour. Classical plastic substrates are two-dimensional, and usually promote cellular proliferation and inhibit differentiation. Understanding cell behaviour within complex multicellular tissues requires the systematic study of cells within the context of specific model microenvironments. A model system must mimic, to a certain degree, the in vivo situation, but, at the same time, can significantly reduce its complexity. There is increasing agreement that moving up to the third dimension provides a more physiologically-relevant and predictive model system. Moreover, many cellular processes (morphogenesis, organogenesis and pathogenesis) have been confirmed to occur exclusively when cells are ordered in a three-dimensional (3D) manner. In order to achieve the desired in vivo phenotype, researchers can use microporous membranes for improved in vitro cell culture experiments. In the present review, we discuss the applications of filter-well technology for the advanced 3-D cell culture of human pulmonary cells.
KarpG. (2010). Cell Biology: International Student Version, 6th edn, 860pp. Hoboken, NJ, USA: John Wiley & Sons.
2.
LutolfM.P. & HubbellJ.A. (2005). Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nature Biotechnology23, 47–55.
3.
JungwooL., CuddihyM.J. & KotovN.A. (2008). Three-dimensional cell culture matrices: State of the art. Tissue Engineering Part B Reviews14, 62–86.
4.
DunsmoreS.E. & RannelsD.E. (1996). Extracellular matrix biology in the lung. American Journal of Physiology: Lung Cellular & Molecular Physiology270, 3–27.
5.
PankajakshanD. & KrishnanL.K. (2009). Design of fibrin matrix composition to enhance endothelial cell growth and extracellular matrix deposition for in vitro tissue engineering. Artificial Organs23, 16–25.
6.
PampaloniF., ReynaudE.G. & StelzerE.H.K. (2007). The third dimension bridges the gap between cell culture and live tissue. Nature Reviews. Molecular Cell Biology8, 839–845.
7.
MayrL.M. & FuerstP. (2008). The future of high-throughput screening. Journal of Biomolecular Screening13, 443–448.
8.
AgiusL. (1987). Human liver in vitro techniques for metabolic studies. Bailliere's Clinical Endocrinology & Metabolism1, 999–1021.
9.
BéruBéK.A., AufderheideM., BrehenyD., ClothierR., CombesR., DuffinR., ForbesB., GaçaM., GrayA., HallI., KellyM., LethemM., LiebschM., MerollaL., MorinJ.P., SeagraveJ., SwartzM.A., TetleyT.D. & UmachandranM. (2009). In vitro models of inhalation toxicity and disease: The report of a FRAME workshop. ATLA37, 89–141.
10.
BéruBéK.A., GibsonC., JobC. & PrytherchZ. (2010). Human lung tissue engineering: A critical tool for safer medicines. Cell & Tissue Banking [Epub ahead of print].
11.
LantelmeE., LucaO., PaolaP., ValentinaT., MarioD.M., AntonioA., StefaniaM. & ClaudiaG. (2008). An in vitro model of T cell receptor revision in mature human CD8+ T cells. Molecular Immunology45, 328–337.
12.
RoguetR. & SchaeferH. (1997). Overview of in vitro cell culture technologies and pharmaco-toxicological applications. Toxicology in Vitro11, 591–599.
13.
ThomasL.H. & HowardC.J. (1974). Effect of Mycoplasma dispar, Mycoplasma bovirhinis, Acholeplasma laidlawii and T-mycoplasmas on explant cultures of bovine trachea. Journal of Comparative Pathology84, 193–201.
14.
LechnerJ.F., McClendonI.A., LaVeckM.A., ShamsuddinA.M. & HarrisC.C. (1983). Differential control by platelet factors of squamous differentiation in normal and malignant human bronchial epithelial cells. Cancer Research43, 5915–5921.
HillE.M., ElingT. & NettesheimP. (1998). Differentiation dependency of eicosanoid enzyme expression in human tracheobronchial epithelial cells. Toxicological Letters96, 239–244.
17.
KeY., GerwinB.I., RuskieS.E., PfeiferA.M., HarrisC.C. & LechnerJ.F. (1990). Cell density governs the ability of human bronchial epithelial cells to recognise serum and transforming growth factor beta-1 as squamous differentiation-inducing agents. American Journal of Pathology137, 833–843.
18.
EngelhardtJ.F., AllenE.D. & WilsonJ.M. (1991). Reconstitution of tracheal grafts with a genetically modified epithelium. Proceedings of the National Academy of Sciences of the USA88, 11,192–11,196.
19.
TerzaghiM., NettesheimP. & WilliamsM.L. (1978). Repopulation of denuded tracheal grafts with normal, preneoplastic, and neoplastic epithelial cell populations. Cancer Research38, 4546–4553.
20.
AdlerK.B., SchwartzJ.E., WhitcuttM.J. & WuR. (1987). A new chamber system for maintaining differentiated guinea pig respiratory epithelial cells between air and liquid phases. BioTechniques5, 462–466.
21.
MartinW.R., BrownC., ZhangY.J. & WuR. (1991). Growth and differentiation of primary tracheal epithelial cells in culture: Regulation by extracellular calcium. Journal of Cellular Physiology147, 138–148.
22.
GrayT.E., GuzmanK., DavisC.W., AbdullahL.H. & NettesheimP. (1996). Mucociliary differentiation of serially passaged normal human tracheobronchial epithelial cells. American Journal of Respiratory Cell & Molecular Biology14, 104–112.
23.
YamayaM., FinkbeinerW.E., ChunS.Y. & WiddicombeJ.H. (1992). Differentiated structure and function of cultures from human tracheal epithelium. American Journal of Physiology: Lung Cellular & Molecular Physiology6, L713–L724.
24.
KaartinenL., NettesheimP., AdlerK.B. & RandellS.H. (1993). Rat tracheal epithelial cell differentiation in vitro. In Vitro Cellular & Developmental Biology: Animal29A, 481–492.
25.
KondoM., FinkbeinerW.E. & WiddicombeJ.H. (1993). Cultures of bovine tracheal epithelium with differentiated ultrastructure and ion transport. In Vitro Cellular & Developmental Biology: Animal29A, 19–24.
26.
MochizukiH., MorikawaA., TokuyamaK., KuroumeT. & ChaoA.C. (1994). The effect of non-steroidal anti inflammatory drugs on the electrical properties of cultured dog tracheal epithelial cells. European Journal of Pharmacology252, 183–188.
27.
BishopA.E. & RipponH.E. (2006). Stem cells — potential for repairing damaged lungs and growing human lungs for transplant. Expert Opinion Biological Theory6, 751–758.
28.
LaneS., RipponH.J. & BishopA.E. (2007). Stem cells in lung repair and regeneration. Regenerative Medicine2, 407–415.
29.
BalharryD., SextonK. & BéruBéK.A. (2008). An in vitro approach to assess the toxicity of inhaled tobacco smoke components: Nicotine, cadmium, formaldehyde and urethane. Toxicology244, 66–76.
30.
SextonK., BalharryD. & BéruBéK.A. (2008). Genomic biomarkers of pulmonary exposure to tobacco smoke components. Pharmacogenetics & Genomics18, 853–860.
31.
PrytherchZ. (2010). Human Tissue Equivalents of Respiratory Epithelia: In Vitro Alternatives for Screening of Candidate Respiratory Drugs, 234pp. PhD Thesis, Cardiff University, Wales, UK: Cardiff University.
32.
ZalewskiP.D. & RuffinR.E. (2008). Apoptosis-regulatory factors as potential drug targets in the epithelium of normal and inflamed airways. Current Molecular Pharmacology1, 38–49.
33.
KnightD.A. & HolgateS.T. (2003). The airway epithelium: Structural and functional properties in health and disease. Respirology8, 432–446.
HubbardR. (2006). The burden of lung disease. Thorax61, 557–558.
36.
European Commission (2006). Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. Official Journal of the European UnionL396, 30.12.2006, 1–849.
37.
European Union (2003). Directive 2003/15/EC of the European Parliament and of the Council of 27 February 2003 amending Council Directive 76/768/EEC on the approximation of the laws of the Member States relating to cosmetic products. Official Journal of the European UnionL66, 11.03.2003, 26–35.
38.
BradleyA.J., NadiaA.B. & RobinA.F. (2009). 3D cell culture opens new dimensions in cell-based assays. Drug Discovery Today14, 102–107.
39.
PittA.M., GabrielsJ.E., BadmingtonF., McDowellJ., GonzalesL. & WaughM.E. (1987). Cell culture on a microscopically transparent microporous membrane. BioTechniques5, 162–171.
40.
GrobsteinC. (1953). Morphogenetic interaction between embyronic mouse tissues separated by a membrane filter. Nature, London172, 869–870.
41.
HandlerJ.S., PrestonA.S. & SteeleR.E. (1984). Factors affecting the differentiation of epithelial transport and responsiveness to hormones. Federation Proceedings15, 2221–2224.
42.
SteeleR.E., PrestonA.S., JohnsonJ.P. & HandlerJ.S. (1986). Porous-bottom dishes for culture of polarized cells. American Journal of Physiology25, C136–C139.
43.
ByersS.W., HadleyM.A., DjakiewD. & DymM. (1986). Growth and characterization of polarized monolayers of epididymal epithelial cells and sertoli cells in dual environment culture chambers. Journal of Andrology7, 59–68.
44.
PittA.M. & GabrielsJ.E. (1986). Epithelial cell culture on a microporous membrane. American Biotechnology Laboratory4, 38–45.
45.
PittA.M. (1987). The non-specific protein binding of polymeric microporous membranes. Journal of Parenteral Science & Technology41, 110–113.
46.
GoelV., AccomazzoM.A., DiLeoA.J., MeierP., PittA. & PluskalM. (1992). Deadend microfiltration: Applications, design and cost. In Membrane Handbook (ed. HoW.S. & SirkarK.K.), pp. 506–565. New York, NY, USA: Van Nostrand Reinhold.
47.
US FDA (2000). Guidance for Industry — Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System, 13pp. Silver Spring, MD, USA: US Department of Health and Human Services, Food and Drug Administration. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070246.pdf (Accessed 30.10.10).
48.
BéruBéK.A., BalharryD., JonesT., MorenoT., HaydenP., SextonK., HicksM., MerollaL., TimblinC., ShuklaA. & MossmanB. (2006). Characterization of airborne particulate matter and related mechanisms of toxicity: An experimental approach. In Air Pollution and Health (ed. MaynardR.), pp. 69–110. London, UK: Imperial College Press.
49.
MinuthW.W., StrehlR. & SchumacherK. (2005). Concepts of tissue creation. In Tissue Engineering: Essentials for Daily Laboratory Work, pp. 113–129. Weinheim, FRG: Wiley-VCH Verlag GmbH & Co. KGaA.
50.
BallardS.T. & TaylorA.E. (1994). Bioelectric properties of proximal bronchiolar epithelium. American Journal of Physiology267, L79–L84.
51.
HaydenP. & JacksonG.R. (2006). Long term culture of pseudo-stratified tracheal bronchial EpiAirway™ Tissues. MatTek Corporation Technical Report394. Ashland, MA, USA: MatTek Corporation. Available at: http://www.mattek.com/pages/abstracts/394 (Accessed 30.10.10).
52.
JacksonG.R., BolmarcichJ., KlausnerM. & HaydenP.J. (2010). Timecourse of TH2 cytokine-induced goblet cell hyperplasia in the EpiAirway in vitro human airway model. American Journal of Respiratory & Critical Care Medicine181, A1744.
53.
SedelnikovaO.A., NakamuraA., KovalchukO., KoturbashI., MitchellS.A., MarinoS.A., BrennerD.J. & BonnerW.M. (2007). DNA double-strand breaks form in bystander cells after microbeam irradiation of three-dimensional human tissue models. Cancer Research67, 4295–4302.
54.
AguR.U., ValivetiS., EarlesD.C., KlausnerM., HaydenP.J., WermelingD.P. & StinchcombA.L. (2004). Intranasal delivery of recombinant human parathyroid hormone [HPTH (1-34)] teriparatide in rats. Endocrine Research30, 455–467.
55.
AguR.U., ValivetiS., PaudelK.S., KlausnerM., HaydenP.J. & StinchcombA.S. (2006). Permeation of Win 55, 212-2, a potent cannabinoid receptor agonist, across human tracheo-bronchial tissue (EpiAirway™). Journal of Pharmacy & Pharmacology58, 1–7.
56.
LeonardA.K., SilenoA.P., MacEvillyC., FoerderC.A., QuayS.C. & CostantinoH.R. (2005). Development of a novel high-concentration galantamine formulation suitable for intranasal delivery. Journal of Pharmaceutical Sciences94, 1736–1746.
57.
LeonardA.K., SilenoA.P., BrandtG.C., FoerderC.A., QuayS.C., CostantinoH.R. (2007). In vitro formulation optimization of intranasal galantamine leading to enhanced bioavailability and reduced emetic response in vivo. International Journal of Pharmaceutics335, 138–146.
58.
LamharziN., SilenoT., EitingK.T., TemplinM., HaugaardK.D., HoustonM., CuiK., JohnsonP.H. & ChenS-C. (2007). Peptides and pegylated peptides as intranasal permeation enhancers: Comparison to small molecular excipients. Journal of Pharmaceutical Sciences95, 1364–1371.
59.
BabuR.J., DayalP. & SinghM. (2008). Effect of cyclodextrins on the complexation and nasal permeation of melatonin. Drug Delivery15, 381–388.
60.
Chen-QuayS-C., EitingK.T., LiA.W-A., LamharziN. & QuayS.C. (2009). Identification of tight junction modulating lipids. Journal of Pharmaceutical Sciences98, 2.
61.
FreishtatR.J., WatsonA.M., BentonA.S., IqbalS.F., PillaiD.K., RoseM.C. & HoffmanE.P. (2010). Asthmatic airway epithelium is intrinsically inflammatory and mitotically dyssynchronous. American Journal of Respiratory Cell & Molecular Biology [Epub ahead of print].
62.
WatsonA.M., BentonA.S., RoseM.C. & FrieshtatR.J. (2010). Cigarette smoke alters tissue inhibitor of metalloproteinase 1 and matrix metalloproteinase 9 levels in the basolateral secretions of human asthmatic bronchial epithelium in vitro. Journal of Investigative Medicine58, 725–729.
63.
Triana-BaltzerG.B., BabizkiM., ChanM.C.W., WongA.C.N., AschenbrennerL.M., CampbellE.R., LiQ-X., ChanR.W.Y., PeirisJ.S.M., NichollsJ.M. & FangF. (2009). DAS181, a sialidase fusion protein, protects human airway epithelium against influenza virus infection: An in vitro pharmacodynamic analysis. Journal of Antimicrobial Chemotherapy65, 275–284.
64.
PalermoL.M., PorottoM., YokoyamaC.C., PalmerS.G., MungallB.A., GreengardO., NiewieskS. & MosconaA. (2010). Human parainfluenza virus infection of the airway epithelium: The viral hemagglutinin-neuraminidase regulates fusion protein activation and modulates infectivity. Journal of Virology83, 6900–6908.
65.
SharmaM., SchoopR. & HudsonJ.B. (2010). The efficacy of Echinacea in a 3-D tissue model of human airway epithelium. Phytotherapy Research24, 900–904.
66.
GompertsB.N., KimL.J., FlahertyS.J. & HackettB.P. (2007). IL-13 regulates cilia loss and foxj1 expression in human airway epithelium. American Journal of Respiratory Cell & Molecular Biology37, 339–346.
GibbS. (2008). A review of the National Research Council report Toxicity Testing in the 21st Century: A Vision and Strategy. Reproductive Toxicology25, 136–138.
